• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同天然来源的化合物抗三阴性乳腺癌:全面综述。

Compounds from diverse natural origin against triple-negative breast cancer: A comprehensive review.

机构信息

Department of Biotechnology, Faculty of Engineering, Karpagam Academy of Higher Education, Coimbatore, India.

Department of Chemistry, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Chengalpattu, India.

出版信息

Chem Biol Drug Des. 2023 Jan;101(1):218-243. doi: 10.1111/cbdd.14172. Epub 2022 Nov 15.

DOI:10.1111/cbdd.14172
PMID:36323650
Abstract

Triple-negative breast cancer (TNBC) is caused due to the lack of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor 2 (HER2) expression. Triple-negative breast cancer is the most aggressive heterogeneous disease that is capable of producing different clones and mutations. Tumorigenesis in TNBC is caused due to the mutation or overexpression of tumor suppressor genes. It is also associated with mutations in the BRCA gene which is linked to hereditary breast cancer. In addition, PARP proteins and checkpoint proteins also play a crucial function in causing TNBC. Many cell signaling pathways are dysregulated in TNBC. Even though chemotherapy and immunotherapy are good options for TNBC treatment, the response rates are still low in general. Many phytochemicals that are derived from natural compounds have shown very good inhibitions for TNBC. Natural compounds have the great advantage of being less toxic, having lesser side effects, and being easily available. The secondary metabolites such as alkaloids, terpenoids, steroids, and flavonoids in natural products make them promising inhibitors of TNBC. Their compositions also offer vital insights into inhibitory action, which could lead to new cancer-fighting strategies. This review can help in understanding how naturally occurring substances and medicinal herbs decrease specific tumors and pave the way for the development of novel and extremely efficient antitumor therapies.

摘要

三阴性乳腺癌(TNBC)是由于缺乏雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子 2(HER2)的表达而引起的。三阴性乳腺癌是最具侵袭性的异质性疾病,能够产生不同的克隆和突变。TNBC 的肿瘤发生是由于肿瘤抑制基因的突变或过表达引起的。它也与 BRCA 基因的突变有关,BRCA 基因与遗传性乳腺癌有关。此外,PARP 蛋白和检查点蛋白在导致 TNBC 方面也起着至关重要的作用。许多细胞信号通路在 TNBC 中失调。尽管化疗和免疫疗法是 TNBC 治疗的好选择,但总体反应率仍然较低。许多来源于天然化合物的植物化学物质对 TNBC 表现出很好的抑制作用。天然化合物的优势在于毒性较小、副作用较小、易于获得。天然产物中的生物碱、萜类、甾体和类黄酮等次生代谢物使它们成为 TNBC 有希望的抑制剂。它们的组成也为抑制作用提供了重要的见解,这可能为新的抗癌策略铺平道路。这篇综述可以帮助理解天然物质和草药如何减少特定的肿瘤,并为开发新型、高效的抗肿瘤疗法铺平道路。

相似文献

1
Compounds from diverse natural origin against triple-negative breast cancer: A comprehensive review.不同天然来源的化合物抗三阴性乳腺癌:全面综述。
Chem Biol Drug Des. 2023 Jan;101(1):218-243. doi: 10.1111/cbdd.14172. Epub 2022 Nov 15.
2
The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics.三阴性乳腺癌的演变:从生物学到新型疗法
Am Soc Clin Oncol Educ Book. 2016;35:34-42. doi: 10.1200/EDBK_159135.
3
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.猫乳腺基底样腺癌:一种具有基底样亚型的人类三阴性乳腺癌(TNBC)的潜在模型。
BMC Cancer. 2013 Sep 3;13:403. doi: 10.1186/1471-2407-13-403.
4
Advances in Therapeutic Approaches for Triple-Negative Breast Cancer.三阴性乳腺癌治疗方法的进展。
Clin Breast Cancer. 2021 Oct;21(5):383-390. doi: 10.1016/j.clbc.2020.12.011. Epub 2020 Dec 29.
5
Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I-III breast cancer: ER+/PR+, HER2- vs. triple-negative.化疗相对剂量强度对 I-III 期乳腺癌(ER+/PR+、HER2- 与三阴性)的特定病因和总生存的影响。
Breast Cancer Res Treat. 2018 May;169(1):175-187. doi: 10.1007/s10549-017-4646-1. Epub 2018 Jan 24.
6
Small Molecule Therapeutics in the Pipeline Targeting for Triple-Negative Breast Cancer: Origin, Challenges, Opportunities, and Mechanisms of Action.针对三阴性乳腺癌的在研小分子治疗药物:起源、挑战、机遇和作用机制。
Int J Mol Sci. 2024 Jun 6;25(11):6285. doi: 10.3390/ijms25116285.
7
BRCA Mutational Status is a Promising Predictive Biomarker for Platinum- based Chemotherapy in Triple-Negative Breast Cancer.BRCA 基因突变状态是三阴性乳腺癌铂类化疗的有前途的预测生物标志物。
Curr Drug Targets. 2020;21(10):962-973. doi: 10.2174/1389450121666200203162541.
8
Triple-negative breast cancer molecular subtyping and treatment progress.三阴性乳腺癌分子分型及治疗进展。
Breast Cancer Res. 2020 Jun 9;22(1):61. doi: 10.1186/s13058-020-01296-5.
9
Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer.SIRT1、SIRT3 和 SIRT6 基因的表达对三阴性和激素受体阳性乳腺癌亚型生存的预测作用。
Pathol Oncol Res. 2020 Oct;26(4):2723-2731. doi: 10.1007/s12253-020-00873-5. Epub 2020 Jul 17.
10
Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer.免疫疗法在三阴性乳腺癌患者中的应用进展与困境。
Expert Opin Investig Drugs. 2022 Jun;31(6):567-591. doi: 10.1080/13543784.2022.2049232. Epub 2022 Mar 9.

引用本文的文献

1
A comparative study of healthy lifestyle behaviors and related factors among Iranian male and female adolescents: a cross-sectional study.伊朗青少年男性和女性健康生活方式行为及相关因素的比较研究:一项横断面研究。
BMC Public Health. 2025 Feb 11;25(1):558. doi: 10.1186/s12889-025-21688-6.
2
Cytotoxic Effects of Plant Secondary Metabolites and Naturally Occurring Bioactive Peptides on Breast Cancer Model Systems: Molecular Mechanisms.植物次生代谢物和天然生物活性肽对乳腺癌模型系统的细胞毒性作用:分子机制。
Molecules. 2024 Nov 7;29(22):5275. doi: 10.3390/molecules29225275.
3
Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms.
PARP抑制剂在BRCA突变三阴性乳腺癌中的联合策略:克服耐药机制
Oncogene. 2025 Feb;44(4):193-207. doi: 10.1038/s41388-024-03227-6. Epub 2024 Nov 21.
4
Small Molecule Therapeutics in the Pipeline Targeting for Triple-Negative Breast Cancer: Origin, Challenges, Opportunities, and Mechanisms of Action.针对三阴性乳腺癌的在研小分子治疗药物:起源、挑战、机遇和作用机制。
Int J Mol Sci. 2024 Jun 6;25(11):6285. doi: 10.3390/ijms25116285.
5
The therapeutic potential of natural metabolites in targeting endocrine-independent HER-2-negative breast cancer.天然代谢产物在靶向内分泌非依赖性HER-2阴性乳腺癌方面的治疗潜力。
Front Pharmacol. 2024 Mar 4;15:1349242. doi: 10.3389/fphar.2024.1349242. eCollection 2024.
6
The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production.五味子乙素通过抑制 NLRP3 诱导的白细胞介素-1β产生来对抗三阴性乳腺癌。
Biomolecules. 2024 Jan 5;14(1):74. doi: 10.3390/biom14010074.
7
Recent biological applications of heterocyclic hybrids containing -triazine scaffold.含三嗪骨架的杂环杂化物的近期生物学应用。
RSC Adv. 2023 Oct 17;13(43):30462-30490. doi: 10.1039/d3ra05953g. eCollection 2023 Oct 11.